Gadoteridol Impurity 8 | CAS 294-90-6 - Request Quote
Gadoteridol Impurity 8
| SZ CAT No: | SZ-G032014 |
| CAS No | 294-90-6 |
| Mol.F. | C8H20N4 |
| Mol.Wt. | 172.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gadoteridol Impurity 8 is chemically 1,4,7,10-Tetraazacyclododecane. Gadoteridol Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Gadoteridol Impurity 8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gadoteridol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 294-90-6
Purchase 294-90-6
Order 294-90-6
Enquire 294-90-6
price of 294-90-6
294-90-6 Supplier
294-90-6 Manufacturer
294-90-6 Exporter
buy high quality Gadoteridol Impurity 8
Purchase Gadoteridol Impurity 8
Gadoteridol Impurity 8 suppliers
Gadoteridol Impurity 8 manufacturers
Gadoteridol Impurity 8 price
Order Gadoteridol Impurity 8
Enquire Gadoteridol Impurity 8
Gadoteridol Impurity 8 cost
Gadoteridol Impurity 8 Supplier
Gadoteridol Impurity 8 Distributor
Gadoteridol Impurity 8 for Method Validation
Gadoteridol Reference Standard
Gadoteridol Impurity 8 for ANDA Filing
Gadoteridol Impurity 8 for Forced Degradation Studies
Gadoteridol Impurity 8 Identification Standards
Gadoteridol Impurity 8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


